Search research articles
Contact Us
Filters
Showing results (11-20 of 58) with videos related to
Page
of 6
Sort By:
British Journal of Cancer
|
February 1, 2014
TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients
M J Pajares, J Agorreta, E Salvo, et al.
Nutrients
|
December 23, 2022
<i>Lactiplantibacillus plantarum DSM20174</i> Attenuates the Progression of Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota, Improving Metabolic Risk Factors, and Attenuating Adipose Inflammation
José I Riezu-Boj, Miguel Barajas, Tania Pérez-Sánchez, et al.
Cancer Research
|
September 3, 2004
Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement
Daniel Ajona, Zafira Castaño, Mercedes Garayoa, et al.
Plos One
|
August 10, 2012
Identification of novel deregulated RNA metabolism-related genes in non-small cell lung cancer
Iñaki Valles, Maria J Pajares, Victor Segura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2010
The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression
Teresa Ezponda, María J Pajares, Jackeline Agorreta, et al.
Hepato-Gastroenterology
|
June 1, 1989
A multicenter, randomized, double-blind study comparing once-daily bedtime administration of famotidine and ranitidine in the short-term treatment of active duodenal ulcer
R Alcalá Santaella, J Guardia, J Pajares, et al.
Alimentary Pharmacology & Therapeutics
|
February 1, 1989
A multicentre, randomized, double-blind study comparing nocte famotidine or ranitidine for the treatment of active duodenal ulceration
R Alcalá Santaella, J Guardia, J Pajares, et al.
Digestion
|
January 1, 1989
A multicenter, randomized, double-blind study comparing a daily bedtime administration of famotidine and ranitidine in short-term treatment of active duodenal ulcer
R Alcalá-Santaella, J Guardia, J Pajares, et al.
Molecular Cancer
|
June 1, 2010
TGFBI expression is associated with a better response to chemotherapy in NSCLC
Marta Irigoyen, María J Pajares, Jackeline Agorreta, et al.
International Journal of Cancer
|
October 2, 2012
Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate therapeutic target for NSCLC
Erik Oliemuller, Rafael Peláez, Saray Garasa, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 58) with videos related to
Sort By:
Page
of 6
British Journal of Cancer
|
February 1, 2014
TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients
M J Pajares, J Agorreta, E Salvo, et al.
Nutrients
|
December 23, 2022
<i>Lactiplantibacillus plantarum DSM20174</i> Attenuates the Progression of Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota, Improving Metabolic Risk Factors, and Attenuating Adipose Inflammation
José I Riezu-Boj, Miguel Barajas, Tania Pérez-Sánchez, et al.
Cancer Research
|
September 3, 2004
Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement
Daniel Ajona, Zafira Castaño, Mercedes Garayoa, et al.
Plos One
|
August 10, 2012
Identification of novel deregulated RNA metabolism-related genes in non-small cell lung cancer
Iñaki Valles, Maria J Pajares, Victor Segura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2010
The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression
Teresa Ezponda, María J Pajares, Jackeline Agorreta, et al.
Hepato-Gastroenterology
|
June 1, 1989
A multicenter, randomized, double-blind study comparing once-daily bedtime administration of famotidine and ranitidine in the short-term treatment of active duodenal ulcer
R Alcalá Santaella, J Guardia, J Pajares, et al.
Alimentary Pharmacology & Therapeutics
|
February 1, 1989
A multicentre, randomized, double-blind study comparing nocte famotidine or ranitidine for the treatment of active duodenal ulceration
R Alcalá Santaella, J Guardia, J Pajares, et al.
Digestion
|
January 1, 1989
A multicenter, randomized, double-blind study comparing a daily bedtime administration of famotidine and ranitidine in short-term treatment of active duodenal ulcer
R Alcalá-Santaella, J Guardia, J Pajares, et al.
Molecular Cancer
|
June 1, 2010
TGFBI expression is associated with a better response to chemotherapy in NSCLC
Marta Irigoyen, María J Pajares, Jackeline Agorreta, et al.
International Journal of Cancer
|
October 2, 2012
Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate therapeutic target for NSCLC
Erik Oliemuller, Rafael Peláez, Saray Garasa, et al.
Page
of 6